Analysis of human immunodeficiency virus in semen: Indications of a genetically distinct virus reservoir

Journal of Reproductive Immunology

Volumn 41, Issue 1-2, 1998, Pages 161-176

  Byrn, Randal A ^a   Kiessling, Ann A ^b  

^a VERTEX PHARMACEUTICALS   (United States)

^b Division of Urology   (United States)

Author keywords

HIV protease gene sequence; HIV 1; Phylogenetic analysis; Protease inhibitors; Semen

Indexed keywords

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; GERM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE; MALE; MONONUCLEAR CELL; PHYLOGENY; PRIORITY JOURNAL; SEMEN ANALYSIS; SEXUALLY TRANSMITTED DISEASE; VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; HIV INFECTIONS; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEMEN;

EID: 0032433129     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(98)00056-4     Document Type: Conference Paper

References (54)

1. Baccetti B., Collodel G., Piomboni P. The debate on the presence of HIV-1 virus in human spermatozoa. Perspect. Drug Discovery Design. 5:1996;129-142.
2. Bagasra O., Farzadegan H., Seshamma T., Oakes J.W., Saah A., Pomerantz R.J. Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men. AIDS. 8:1994;1669-1674.
3. Balani S.K., Woolf E.J., Hoagland V.L., Sturgill M.G., Deutch P.J., Yeh K.C., Lin J.H. Disposition of Indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans. Drug Metab. Dispos. 24:1996;1389-1394.
4. Belgau D., Gold D., Selawry H., Moore J., Franzusoff A., Duke R.C. A role for Cd95 ligand in preventing graft rejection. Nature. 377:1995;630-632.
5. Borzy M.S., Connell R.S., Kiessling A.A. Detection of human immunodeficiency virus in cell-free seminal fluid. J. Acquired Immune Defic. Syndr. 1:1988;419-424.
6. Byrn R.A., Zhang D., Eyre R.K.M., Kiessling A.A. HIV-1 in semen: an isolated virus reservoir. Lancet. 350:1997;1141.
7. Cohen M.S., Hoffman I.F., Royce R.A., Kazembe P., Dyer J.R., Daly C.C., Zimba D., Vernazza P.L., Maida M., Fiscus S.A., Eron J.J., Group A.M.R. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet. 349:1997;1868-1873.
8. Condra J.H., Schleif W.A., Blahy O.M., Gabryelski L.J., Graham D.J., Quintero J.C., Rhodes A., Robbins H.L., Roth E., Shivaprakash M.et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature. 374:1995;569-571.
9. Dussaix E., Guetard D., Dauguet C., D'Almeida M., Auer J., Ellrodt A., Montagnier L., Auroux M. Spermatozoa as potential carriers of HIV. Res. Virol. 144:1993;487-495.
10. Eron J.J., Gilliam B., Fiscus S., Dyer J., Cohen M.S. HIV-1 shedding and Chlamydial urethritis. J. Am. Med. Assoc. 275:1996;36.
11. Felsenstein, J., 1995. PHYLIP (phylogenetics inference package) Version 3.57. University of Washington, Seattle.
12. Felsenstien J. Phylogenies from molecular sequences: inference and reliability. Annu. Rev. Genet. 22:1988;521-565.
13. Fitzgerald L.M., Yin H.Z., Kiessling A.A. PCR amplification of HIV and cellular DNA sequences in formaldehyde-fixed, immunoreactive white blood cells. Biotechniques. 15:1993;128-133.
14. Gilliam B.R., Dyer J.R., Fiscus S.A., Marcus C., Zhou S., Wathen L., Freimuth W.W., Cohen M.C., Eron J.J.J. Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:1997;54-60.
15. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Stewart P.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1995;1189-1192.
16. Gupta P., Mellors J., Kingsley L., Riddler S., Singh M.K., Schreiber S., Cronin M., Rinaldo C.R. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J. Virol. 71:1997;6271-6275.
17. Hamed K.A., Winters M.A., Holodniy M., Katzenstein D.A., Merigan T.C. Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy. J. Infect. Dis. 167:1993;798-802.
18. Hammer S., Crumpacker C.R.D.A., Jackson B., Lathey J., Livnat D., Reichelderfer P. Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee. J. Clin. Microbiol. 31:1993;2557-2564.
19. Henry K., Chinnock B.J., Quinn R.P., Fletcher C.V., de Miranda P., Balfour H.H. Jr. Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complex. J. Am. Med. Assoc. 259:1988;3023-3026.
20. Ho D.D., Schooley R.T., Rota T.R., Kaplan J.C., Flynn T., Salahuddin S.Z., Gonda M.A., Hirsch M.S. HTLV-III in semen and blood of a healthy homosexual man. Science. 226:1984;451-453.
21. Jacobsen H., Hanggi M., Ott M., Duncan I.B., Owen S., Andreoni M., Vella S., Mous J. In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies. J. Infect. Dis. 173:1996;1379-1387.
22. Japour A.J., Mayers D.L., Johnson V.A., Kuritzkes D.R., Beckett L.A., Arduino J.M., Lane J., Black R.J., Reichelderfer P.S.R.T.D.A.et al. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group. Antimicrob. Agents Chemother. 37:1993;1095-1101.
23. Kempf D.J., Marsh K.C., Denissen J.F., McDonald E., Vasavanonda S., Flentge C.A., Green B.E., Fino L., Park C.H., Kong X.-I., Wideburg N.E., Saldivar A., Ruiz L., Kati W.M., Sham H.L., Robins T., Stewart K.D., Hsu A., Plattner J.J., Leonard J.M., Norbeck D.W. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc. Natl. Acad. Sci. USA. 92:1995;2484-2488.
24. Kiessling A. Human immunodeficiency virus in semen. Curr. Opin. Urol. 4:1994;60-65.
25. Kiessling, A.A., Fitzgerald, L.M.D.Z., Chhay, H., Brettler, D., Eyre, R.C., Steinberg, J., McGowan, K., Byrn, R.A., 1998. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir. AIDS Res. Hum. Retroviruses. 14, suppl. 1, S33-S41.
26. Kiessling A.A., Lamparelli N., Yin H.Z., Seibel M.M., Eyre R.C. Semen leukocytes: friends or foes? Fertil. Steril. 64:1995;196-198.
27. Krieger J.N., Coombs R.W., Collier A.C., Ho D.D., Ross S.O., Zeh J.E., Corey L. Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission. J. Urol. 154:1995;1035-1040.
28. Krieger J.N., Coombs R.W., Collier A.C., Ross S.O., Chaloupka K., Cummings D.K., Murphy V.L., Corey L. Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. J. Infect. Dis. 163:1991;386-388.
29. Kroodsma K.L., Kozal M.J., Hamed K.A., Winters M.A., Merigan T.C. Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA. J. Infect. Dis. 170:1994;1292-1295.
30. Ksander B.R., Streilein J.W. Regulation of the immune response within privileged sites. Chem. Immunol. 58:1994;117-145.
31. Levy J.A. The transmission of AIDS: the case of the infected cell. J. Am Med. Assoc. 259:1988;3037-3038.
32. Liuzzi G., Bagnarelli P., Chirianni A., Nappa S., Cataldo P.T., Valenza A., Piazza M. Quantitation of HIV-1 genome copy number in semen and saliva. AIDS. 9:1995;651-653.
33. Liuzzi G., Chirianni A., Clementi M., Bagnarelli P.A.V., Tullio P.T., Piazza M. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS. 10:1996;F51-F56.
34. Maddocks S., Setchell B.P. Recent evidence for immune privilege in the testis. J. Reprod. Immunol. 18:1990;9-18.
35. Mermin J.H., Holodniy M., Katzenstein D.A., Merigan T.C. Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. J. Infect. Dis. 164:1991;769-776.
36. Molla A., Korneyeva M., Gao Q., Vasavanonda S., Schipper P.J., Mo H.M., Markowitz M., Chernyavskiy T., Niu P., Lyons N., Hsu A., Granneman G.R., Ho D.D., Boucher C.A., Leonard J.M., Norbeck D.W., Kempf D.J. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nature Medicine. 2:1996;760-766.
37. Olsen G., Shields J. Seminal lymphocytes, plasma and AIDS. Nature. 309:1984;116-117.
38. Quayle A.J., Xu C., Mayer K.H., Anderson D.J. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J. Infect. Dis. 176:1997;960-968.
39. Ratner L., Haseltine W., Patarca R., Livak K.J., Starcich B., Josephs S.J., Doran E.R., Rafalski J.A., Whitehorn E.A., Baumeister K., Ivanoff L., Petteway S.R.J., Pearson M.L., Lautenberger J.A., Papas T.S., Ghrayeb J., Chang N.T., Gallo R.C., Wong-Staal F. Complete nucleotide sequence of the AIDS virus. HTLV-III. Nature. 13:1985;277-284.
40. Ritzen E.M. Testicular relapse of acute lymphoblastic leukemia (ALL). J. Reprod. Immunol. 18:1990;117-121.
41. Royce R.A., Sena A., Cates W., Cohen M.S. Sexual transmission of HIV. New Engl. J. Med. 336:1997;1072-1078.
42. Shetty B.V., Kosa M.B., Khalil D.A., Webber S. Preclinical pharmacokinetics and distribution to tissue of AG1343, an inhibitor of human immunodeficiency virus type 1 protease. Antimicrob. Agents Chemother. 40:1996;110-114.
43. Smith R.F., Smith T.F. Pattern-induced multi-sequence alignment (PIMA) algorithm employing secondary structure-dependent gap penalties for use in comparative protein modelling. Protein Eng. 5:1992;35-41.
44. Swofford, D.L., 1985. PAUP (Phylogenetic Analysis Using Parsimony) user manual. Natural History Survey, Chanpaign Ill, Illinois.
45. Tisdale M., Myers R.E., Maschera B., Parry N.R., Oliver N.M., Blair E.D. Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors. Antimicrob. Agents Chemother. 39:1995;1704-1710.
46. Tomlinson M.J., White A., Barratt C.L., Bolton A.E., Cooke I.D. The removal of morphologically abnormal sperm forms by phagocytes: a positive role for seminal leukocytes? Hum. Reprod. 7:1992;517-522.
47. Tung, K., Yule, T., Smith, H., 1990. Pathogenesis and regulation of testicular autoimmune disease. In: Isidori, A., Fabbri, A., Dufau, M. (Eds.), Hormonal Communicating Events in the Testis. Raven Press, New York, pp. 247-260.
48. Vernazza P.L., Eron J.J., Cohen M.S., van der Horst C.M., Troiani L., Fiscus S.A. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS. 8:1994;1325-1329.
49. Vernazza P.L., Eron J.J., Fiscus S.A. Sensitive method for the detection of infectious HIV in semen of seropositive individuals. J. Virol. Methods. 56:1996;33-40.
50. Vernazza P.L., Gilliam B.L., Dyer J., Fiscus S.A., Eron J.J., Frank A.C., Cohen M.S. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS. 11:1997;987-993.
51. Vernazza P.L., Gilliam B.L., Flepp M., Dyer J.R., Frank A.C., Fiscus S.A., Cohen M.S., Eron J.J. Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS. 11:1997;1249-1254.
52. Xu C., Politch J.A., Tucker L., Mayer K.H., III S.G.S., Anderson D.J. Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J. Infect. Dis. 176:1997;941-947.
53. Yamaguchi K., Byrn R.A. Clinical isolates of HIV-1 contain few pre-existing proteinase inhibitor resistance-conferring mutations. Biochim. Biophys. Acta. 1253:1995;136-140.
54. Zagury D., Leibovitch J., Safai B., Groopman J.E., Feldman M., Sarngadharan M.G., Gallo R.C. HTLV-III in cells cultured from semen of two patients with AIDS. Science. 226:1984;449-451.